The coronary stent market refers to the market for medical devices used to treat coronary artery disease (CAD) by keeping the blocked artery open. Coronary artery disease is a condition that occurs when the arteries that supply blood to the heart become narrow or blocked, which can lead to chest pain (angina) or a heart attack. Coronary stents are small mesh tubes that are inserted into the narrowed or blocked artery to prop it open, allowing blood to flow freely.

The Coronary Stent Market Size was valued at USD 7.5 billion in 2022 and is projected to grow from USD 7.74 Billion in 2023 to USD 9.6 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 3.3% during the forecast period (2023 - 2032).

Coronary stents are utilized in angioplasty for making cross-section of blood vessels wider. The stent will reduce the chest pain along with recovering survivability during acute myocardial infarction. Coronary stents are used for treating cardiac diseases namely coronary artery disease, angina pain and myocardial infarction.

There are many factors that is driving the growth of the coronary stents market. Some of these factors as per the Market Research Future (MRFR) report include increasing prevalence of CAD (coronary artery disease, innovations in coronary stents, increase in research and development of coronary stems, untapped emerging countries offering new market opportunities, lifestyle change diseases, increasing geriatric population, profound increase in healthcare coverage, advanced medical technologies, development of ICT (information and communication technology) and increase in government investment. On the contrary, factors such as high expenditure of procedures related to coronary stents coupled with accessibility of substitutes for CAD treatment is likely to hinder the growth of the coronary stents market.

Market Segmentation

Market Research Future report offers an all-inclusive segmental analysis of the heart stent market on the basis of products and end user.

Based on products, it is segmented into Bioresorbable Vascular Scaffolds, Bare Metal Stents and Drug Eluting Stents. Of these, drug eluting stent is expected to lead the market during the predicted years owing to its increasing acceptance in better patient compliance, angioplasty procedures in comparison to bare metal stents. The bioresorbable stents is expected to expand at the fastest pace.

Based on end users, the coronary stents market is segmented into specialty centers, ambulatory surgical centers, hospitals and clinics and others. Of these, hospitals and clinics will have the maximum market share during the predicted years. This will be followed by the ambulatory surgical centers which will expand at the fastest rate.

Regional Analysis

Based on region, the coronary stents market covers growth opportunities and latest trends across North America, Europe, Asia Pacific and Middle East and Africa. Of these, North America will have a lion’s share in the market due to increasing cases of cardiovascular diseases mainly coronary artery disease, arterial blockage, cardiac arrythmia to name a few. Availability of advanced treatment methods and better therapeutic approaches has affected the growth of the market in this region in a positive way. The other factors that is driving the growth of the coronary stents market here include high disposable income, increasing medical awareness among the people here and existence of leading medical device manufacturers in this region. The coronary stents market in Europe holds the second largest share owing to the increasing support by the government for device manufacturers. Also, expansion of the companies geographically has resulted in a broader reach of medical services and products that has brought tremendous change with regards to acceptance as well as implementation of novel procedures and products. The coronary stents market in the APAC region experienced a huge growth due to the increasing development in the medical domain in the developing countries such as China and India. Besides, increasing medical device companies here, increasing research and development expenditure and increasing funding made by the government has resulted in its fastest growth. On the other hand, the coronary stents market in the Middle East and Africa is expected to have minimal growth opportunities.

Competitive Analysis

The coronary stents market analysis is fragmented and highly competitive. The leading companies which have used strategies such as strategic alliances and mergers and acquisitions have gained a competitive advantage. Besides companies are highly focused to create products that are technologically advanced and deliver efficiency and greater accuracy.

Key Players

The coronary stents market Players include Terumo Corporation, Stentys SA, MicroPort Scientific Corporation, Meril Life Sciences, Medtronic plc, Elixir Medical Corporation, Cook Medical, R. Bard, Inc., Boston Scientific Corporation, Biotronik SE & Co. KG, and Abbott, B. Braun Melsungen AG.

Feb 2019- Biotronik has received approval from the FDA on its Ultrathin Orsiro Stent to treat coronary artery disease. This coronary stent will offer a novel treatment option to healthcare providers that will help in sealing the perforation to prevent blood leakage at the time of the procedure as well as avoid higher invasive surgical procedure or life-threatening complication.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

Contact us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 628 258 0071

Email: sales@marketresearchfuture.com